Biotech

Journal of Huntington's Disease Publishes Benefits of PBT2

MELBOURNE, AUSTRALIA: ...

Sarepta Therapeutics Announces Proposed Public Offering of Common Stock

CAMBRIDGE, MA: ...

Stellar Biotechnologies, Inc. to Host Conference Call at 2:30 pm ET on Tuesday, December 18, 2012 to Provide Business Overview

PORT HUENEME, CA: ...

The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.

PARSIPPANY, NJ and REDWOOD CITY, CA: The Medicines Company Perioperative Franchise Enhanced by Two Major Agreements Today; Marketing Clearance for Post-Surgical Pain Candidate IONSYS Expected in Early 2014 ...

Thallion Common Shares to Commence Trading on the TSX-V as of December 12, 2012

MONTREAL, QUEBEC: ...

Warnex Completes the Sale of its Bioanalytical Services Division and Implements the Consolidation of its Common Shares

LAVAL, QUEBEC: ...

Biotie's Tozadenant (SYN115) Meets Primary and Multiple Secondary Endpoints in Phase 2b Study in Parkinson's Disease

TURKU, FINLAND: Biotie's Tozadenant (SYN115) Meets Primary and Multiple Secondary Endpoints in Phase 2b Study in Parkinson's Disease ...

Acura Pharmaceuticals Launches Next Generation Cold Medicine to Aid in the Fight Against Meth

PALATINE, IL: Nexafed(R)'s Abuse-Deterrent Technology Disrupts Conversion of Pseudoephedrine to Dangerous Illegal Drug Methamphetamine Without Compromising Effective Nasal-Congestion Relief ...

Threshold Pharmaceuticals Announces Presentation and Webcast at Oppenheimer 23rd Annual Healthcare Conference

SOUTH SAN FRANCISCO, CA: ...

Functional Technologies Reports Management Changes

VANCOUVER, BRITISH COLUMBIA: ...